Look for:

Our offer for

Research Detail

2022/04/14 / Erste Group Research

New impulses with starting US reporting season

The global equity market remains in a sideways trend. The positive expected global earnings growth of +7.5% in 2022 is set against sharply higher commodity prices, increased yields in the US (2Y government bonds: 2.4%) and sanctions uncertainties due to the Russian war in Ukraine.

With the reporting season starting in the US this week, new impetus is coming to the stock market. For Q1 2022, the estimated earnings growth rate for the S&P 500 is +4.5% (y/y). Over the past five years, on average, about 77% of companies have reported better-than-expected earnings. The positive growth surprise has been about +9%. So, historically, we can expect actual growth to be well above +4.5% at the end of the reporting season.

Recommendation changes: Allianz, Novartis, Nutiren, AMD, TSMC, SVB Financial.

Allianz: 2021 profit rose to EUR 9.98 bn (+35% y/y), positive outlook
Novartis: operating margin rises to 22.1%, efficiency gains & share buyback program

PDF Download Download PDF (5.4MB)

General information

AuthorErste Group Research
Date2022/04/14
Languageen
Product nameRecommendation List
Topic in focusEquities
Economy in focusEurozone, Germany, United States
Currency in focusEuro, US Dollar
Sector in focusAutomobiles & Parts, Banks, Basic Resources, Chemicals, Construction & Material, Financial Services, Food & Beverage, Health Care, Industrial Goods & Services, Insurance, Media, Oil & Gas, Personal & Household Goods, Retail, Technology, Telecommunications, Travel & Leisure, Utilities
Download

Related financial instruments

Page 3 of 4
Name  ISIN# Erste Group products
Johnson & JohnsonUS47816010460
JPMorganUS46625H10050
KeringFR00001214850
LOrealFR00001203210
LVMHFR00001210140
MastercardUS57636Q10400
McDonaldsUS58013510170
Mercedes-Benz GroupDE00071000002
Meta PlatformsUS30303M10270
MicrosoftUS59491810450
MondelezUS60920710580
NestleCH00388633500
NikeUS65410610310
NovartisCH00120052670
PepsiCoUS71344810810
PfizerUS71708110350
Procter & GambleUS74271810910
Rio TintoGB00071887570
Roche HoldingCH00120321130
RWEDE00070371293
Samsung ElectronicsKR70059300030
SanofiFR00001205780
SAPDE00071646004
ShellGB00B03MLX290
SiemensDE00072361010



Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer